Mana Aizawa

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

M. Hino, K. Ishizawa, I. Matsumura, 2022, International Journal of Hematology.

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

M. Hino, K. Ishizawa, I. Matsumura, 2022, International Journal of Hematology.

Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial

M. Kudo, J. Furuse, M. Kurosaki, 2021, Liver Cancer.

First-line avelumab + axitinib in patients with advanced hepatocellular carcinoma: Results from a phase 1b trial (VEGF Liver 100).

M. Kudo, J. Furuse, M. Kurosaki, 2019, Journal of Clinical Oncology.